Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100049/S038

LINX Reflux Management System

Torax Medical · Decision date Oct 8, 2025

FDA DECISIONP100049/S038

What did the FDA approve?

FDA records P100049/S038 as a supplement to PMA P100049, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Oct 8, 2025.

FDA approval order statement

for the manufacturing site change.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 8, 2025
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P100049/S038
Regulatory pathway
PMA supplement
Applicant
Torax Medical
Product code
LEI
Decision code
APPR
Decision date
Oct 8, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX.

Applicant
Torax Medical
Product code
LEI
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P100049/S038 received

    Application receipt date recorded by FDA.

  2. P100049/S038 · FDA decision

    Normal 180 Day Track No User Fee

  3. P100049/S040 · Related supplement

    LINX Reflux Management System

  4. P100049/S041 · Related supplement

    LINX Reflux Management System

Timeline entries are records held by MedtechLedger for P100049. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100049

Product / regulatory recordCompanyPathwayDecision dateSource
Torax MedicalPMA supplementJan 16, 2026FDA
Torax MedicalPMA supplementJan 16, 2026FDA

Explore the linked device profile

Other records with product code LEI

Product / regulatory recordCompanyPathwayDecision dateSource
Implantica CE Reflux , Ltd.PMA approvalAug 20, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Torax Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
4545 Creek Rd., Cincinnati, OH, 45242

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records